FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 20 filers reported holding FREELINE THERAPEUTICS HLDGS in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 1,361,064 | $24,853,000 | 7.00% |
| Novo Holdings A/S | 2,361,229 | $43,116,000 | 1.85% |
| Ally Bridge Group (NY) LLC | 425,000 | $7,761,000 | 1.33% |
| TFG Asset Management GP Ltd | 750,000 | $13,695,000 | 0.92% |
| SECTORAL ASSET MANAGEMENT INC | 657,494 | $12,006,000 | 0.85% |
| FRAZIER MANAGEMENT LLC | 550,000 | $10,043,000 | 0.77% |
| Eventide Asset Management | 2,485,656 | $44,266,000 | 0.68% |
| Ovata Capital Management Ltd | 14,981 | $274,000 | 0.09% |
| AXA S.A. | 551,476 | $10,070,000 | 0.03% |
| Woodline Partners LP | 25,932 | $474,000 | 0.01% |